OUTLOOK THERAPEUTICS, INC. Current Liabilities
OUTLOOK THERAPEUTICS, INC. (OTLK) had Current Liabilities of $28.68 million as of 2026-06-30, per its 10-Q filed 2026-08-18.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-18
- 2026-06-30: Liabilities, Current $28.68M.
- 2026-03-31: Liabilities, Current $38.88M.
- 2025-12-31: Liabilities, Current $49.06M.
- 2025-09-30: Liabilities, Current $45.81M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $28.68M 10-Q · filed 2026-08-18 |
| 2026-03-31 | $38.88M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $49.06M 10-Q · filed 2026-02-17 |
| 2025-09-30 | $45.81M 10-Q · filed 2026-08-18 |
| 2025-06-30 | $31.49M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $24.82M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $48.24M 10-Q · filed 2025-02-14 |
| 2024-09-30 | $42.55M 10-K · filed 2025-12-19 |
| 2024-06-30 | $42.55M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $54.08M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $45.97M 10-Q · filed 2024-02-14 |
| 2023-09-30 | $46.73M 10-K · filed 2024-12-27 |
| 2023-06-30 | $49.93M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $43.53M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $15.08M 10-Q · filed 2023-02-14 |
| 2022-09-30 | $19.73M 10-K · filed 2023-12-22 |
| 2022-06-30 | $18.43M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $31.41M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $19.95M 10-Q · filed 2022-02-14 |
| 2021-09-30 | $6.75M 10-K · filed 2022-12-29 |
| 2021-06-30 | $19.64M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $23.90M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $12.12M 10-Q · filed 2021-02-16 |
| 2020-09-30 | $15.89M 10-K · filed 2021-12-23 |
| 2020-06-30 | $18.45M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $23.71M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $20.10M 10-Q · filed 2020-02-14 |
| 2019-09-30 | $20.29M 10-K · filed 2020-12-23 |
| 2019-06-30 | $23.22M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $26.99M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $27.54M 10-Q · filed 2019-02-14 |
| 2018-09-30 | $32.04M 10-K · filed 2019-12-19 |
| 2018-06-30 | $32.26M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $31.75M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $31.20M 10-Q · filed 2018-02-14 |
| 2017-09-30 | $28.74M 10-K · filed 2018-12-18 |
| 2017-06-30 | $39.27M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $34.78M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $32.13M 10-Q · filed 2017-02-14 |
| 2016-09-30 | $20.44M 10-K · filed 2017-12-29 |
| 2016-06-30 | $22.94M 10-Q · filed 2016-08-15 |
| 2016-03-31 | $35.98M 10-Q · filed 2016-06-27 |
| 2015-09-30 | $37.04M 10-K · filed 2016-12-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |